LTS InsightsLTS Insights

INSIGHTS

LTS InsightsLTS Insights

INSIGHTS

Translating our IP into insight.

This section contains our latest scientific and commercial content, from technical white papers and webcasts to shorter blog pieces on a range of subjects. All written to inform, inspire and showcase our innovations.

White Paper

  • September 7, 2022

    Interview with Dr. Mike Schaefers, Chief Commercial Officer at LTS

    read more
  • LTS Lohmann: S Ketamine OTF
    August 10, 2022

    S-ketamine oral thin film – population pharmacokinetics and pharmacodynamics of S-ketamine, S-norketamine and S-hydroxynorketamine

    read more
  • LTS: In vitro to in vivo:
    July 4, 2022

    In vitro to in vivo: De-risking the critical path from laboratory to clinical trial for transdermal therapies

    read more
VIEW ALL WHITE PAPERS

Webcasts

  • LTS-Academy - OTF as a viable dosage form for pain relief
    August 14, 2022

    LTS-Academy: OTF as a viable dosage form for pain relief

    read more
  • Transdermal Patches - De-risking concept for the in vitro to in vivo translation using new prediction tools
    November 19, 2021

    Transdermal Patches – De-risking concept for the in virto to in vivo translation using new prediction tools

    read more
  • LTS Webcast - Micro Array Patches – The future of pain-free injections, self-applied by the patient
    October 15, 2020

    Micro Array Patches – The future of pain-free injections, self-applied by the patient

    read more
VIEW ALL WEBCASTS

What’s new in our blog?

LTS Visit our blog

In our blog you will find our library of thought leadership articles, webcasts and animation videos covering a range of subjects we are passionate about – from technologies to therapies and beyond.

Visit our blog